Is Iovance Biotherapeutics, Inc. (IOVA) a Buy, Sell, or Hold?
NASDAQ : IOVA
Iovance Biotherapeutics, Inc. — Earnings Estimates
$4.9 USD
-$0.09 (-1.8%)
- Volume
- 13.21M
- Average Volume
- 15.27M
- Market Capitalization
- $2.19B
- P/E Ratio
- -5.33
- Dividend Yield
- 0.00%
- Price Target
- $5.00
- Year High
- $5.64
- Year Low
- $1.76
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.60
Annual earnings financials
IOVA financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
IOVA Estimated and Actual Revenue by Quarter
IOVA Estimated and Actual EPS by Quarter
IOVA Analyst Forecasts — EBITDA & EBIT
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2027-12-31 | 2 | -29.42M | -27.35M | -28.2M | -29.42M | -27.35M | -28.2M |
| 2027-09-30 | 2 | -25.93M | -24.1M | -24.85M | -25.93M | -24.1M | -24.85M |
| 2027-06-30 | 2 | -24.58M | -22.85M | -23.56M | -24.58M | -22.85M | -23.56M |
| 2027-03-31 | 2 | -22.53M | -20.95M | -21.6M | -22.53M | -20.95M | -21.6M |
| 2026-12-31 | 2 | -22.47M | -20.89M | -21.54M | -22.47M | -20.89M | -21.54M |
| 2026-09-30 | 5 | -19.49M | -18.81M | -19.15M | -19.49M | -18.81M | -19.15M |
IOVA Analyst Forecasts — Net Income & SGA Expense
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2027-12-31 | 2 | -18.65M | -16.97M | -17.66M | 2.56B | 2.75B | 2.63B |
| 2027-09-30 | 2 | -27.14M | -24.69M | -25.7M | 2.25B | 2.42B | 2.32B |
| 2027-06-30 | 2 | -39.7M | -36.11M | -37.58M | 2.13B | 2.3B | 2.2B |
| 2027-03-31 | 2 | -46.15M | -41.98M | -43.69M | 1.96B | 2.11B | 2.02B |
| 2026-12-31 | 2 | -50.14M | -45.61M | -47.47M | 1.95B | 2.1B | 2.01B |
| 2026-09-30 | 5 | -53.37M | -47.09M | -50.23M | 1.76B | 1.82B | 1.79B |
IOVA Analyst Forecasts — Revenue & EPS
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2027-12-31 | 2 | 136.74M | 147.1M | 141M | 1 | -0.04457414 | -0.04054417 | -0.0422 |
| 2027-09-30 | 2 | 120.52M | 129.64M | 124.27M | 1 | -0.06485431 | -0.05899081 | -0.0614 |
| 2027-06-30 | 2 | 114.24M | 122.9M | 117.8M | 1 | -0.09485207 | -0.08627647 | -0.0898 |
| 2027-03-31 | 2 | 104.74M | 112.67M | 108M | 1 | -0.11027 | -0.1003 | -0.1044 |
| 2026-12-31 | 2 | 104.46M | 112.37M | 107.71M | 1 | -0.11981 | -0.10898 | -0.11343 |
| 2026-09-30 | 5 | 94.07M | 97.47M | 95.77M | 5 | -0.12752 | -0.11252 | -0.12002 |